Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02710331
PHASE1

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III

Sponsor: Yale University

View on ClinicalTrials.gov

Summary

The overarching goal of this study is to characterize the effects of ethanol and cannabinoids on simulated driving and related cognition.

Key Details

Gender

All

Age Range

21 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2016-03

Completion Date

2025-12

Last Updated

2025-04-09

Healthy Volunteers

Yes

Interventions

DRUG

Active Dronabinol

10 mg capsule of Dronabinol will be administered orally.

DRUG

Placebo

Control: no alcohol, administered for \~80 minutes.

DRUG

Placebo

Control: Placebo pill (no active cannabinoids) administered orally.

DRUG

Active Ethanol

Target BrAC of 0.04% reached over 20 minutes and then clamped to maintain this dose for an additional 60 minutes. This dose is equivalent to consuming approximately 2 drinks over 1 hour. Administered over a total of 80 minutes.

Locations (1)

Biological Studies Unit, VA Connecticut Healthcare System

West Haven, Connecticut, United States